Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sleep quality and delirium prevention after major urological surgery
IRCT20250623066224N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative delirium (POD) and sleep disorder comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Incidence of postoperative delirium and Postoperative sleep quality. Started Aug 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)sleep disorder
Beyond the preview
Go deeper on IRCT20250623066224N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250623066224N1.